No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
DOCS240517C35000
- 0.05
- 0.000.00%
15min DelayTrading May 14 11:28 ET
0.24High0.05Low
0.24Open0.05Pre Close600 Volume501 Open Interest35.00Strike Price3.56KTurnover207.32%IV49.15%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.05Time Value100Contract SizeAmericanOptions Type0.0295Delta0.0143Gamma470.00Leverage Ratio-0.0357Theta0.0001Rho13.86Eff Leverage0.0015Vega
Intraday
- 5D
- 1D
News
8 Out of 12 S&P 500 Healthcare Companies Beat Profit Consensus This Week: Earnings Scorecard
Doximity, Inc.'s (NYSE:DOCS) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
With its stock down 12% over the past three months, it is easy to disregard Doximity (NYSE:DOCS). However, stock prices are usually driven by a company's financial performance over the long term, wh
Global EHealth Market Is Predicted to Exhibit Remarkable Growth by 2030, Predicts DelveInsight | Key Companies in the Market - Athenahealth, Doximity, Epic Systems Corporation, Koninklijke Philips, Medtronic, IBM, Optum, Medhost
New York, USA, April 30, 2024 (GLOBE NEWSWIRE) -- Global eHealth Market is Predicted to Exhibit Remarkable Growth by 2030, Predicts DelveInsight | Key Companies in the Market - Athenahealth, Doximity, Epic Systems
Analysts Offer Insights on Healthcare Companies: Koninklijke Philips (PHG), Doximity (DOCS) and R1 RCM (RCM)
Doximity's Strong Market Position Amidst Economic Headwinds: A Balanced Hold Recommendation
Express News | NYSE Order Imbalance 53816.0 Shares on Sell Side
Comments
Doximity's high P/E ratio is backed by its promising earnings outlook. Shareholders, confident in future earnings, are holding onto their shares. The company's robust earnings growth and positive future outlook bolster its share price.
Investors Still Waiting For A Pull Back In Doximity, Inc. (NYSE:DOCS) 2
The telehealth market shone brightly, valued at $128.12 billion. The market is poised for a stellar ascent, forecasted to skyrocket from $142.96 billion in 2023 to a staggering $504.24 billion by 2030. This growth, marked by a robust 19.7% CAGR, highlights the sector’s burgeoning potential, as noted by Fortune Business Insights. The growth of telehealth is significant. It underscores its transformative impact on the future landscape of healthcare.
![]()
$Teladoc Health(TDOC.US$
A...
A...
+2
7
Analysts from William Blair and Raymond James rate DOCS shares as 'Outperform', remaining optimistic about the company's future. They find the solid results and improved guidance range to be a positive step.
Doximity's underpriced shares and forecasted profitability increase its appeal among big growth investors. Its bright future prospects are not entirely factored into its current share price. However, it's recommended to examine the company's finance before investment.
Doximity's outlook suggests potential headwinds. Toast's share price drop may indicate future performance caution, while Matterport's disappointing guidance raises growth concerns. Unity's growth potential is high despite a weakening share price that suggests lower revenue guidance concerns. 2U's poor estimate meeting and gross margin decline affect investor sentiment negatively.
Read more